MiNK Therapeutics Inc. (INKT)
undefined
undefined%
At close: undefined

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue - 2.70B - - 689.63K
Cost of Revenue 204.62K 30.95B 28.36B 55.06K -
Gross Profit -204.62K -28.24B -28.36B -55.06K 689.63K
Operating Income -22.92M -30.95M -28.36M -14.64M -22.28M
Interest Income 463.26K 253.32K 2.43K 2.44K 1.56K
Pretax Income -22.46M -27.99M -30.21M -16.24M -23.80M
Net Income -22.46M -24.78M -23.11M -15.68M -25.91M
Selling & General & Admin 7.43M 7.83M 4.64M 1.29M 3.83M
Research & Development 15.49M 23.12M 13.97M 9.51M 19.65M
Other Expenses - 2.70M -9.53M -3.00M 551.24K
Operating Expenses 22.92M 30.95M 18.61M 10.80M 23.48M
Interest Expense - 253.32K 2.43M 2.44M 1.56M
Selling & Marketing Expenses - - - - -
Cost & Expenses 22.92M 30.95M 18.61M 10.80M 23.48M
Income Tax - -3.21M -7.10M -560.38K 2.11M
Shares Outstanding (Basic) 34.36M 33.67M 33.48M 33.09M 33.09M
Shares Outstanding (Diluted) 34.36M 33.67M 33.48M 33.09M 33.09M
EPS (Basic) -0.65 -0.74 -0.69 -0.47 -0.78
EPS (Diluted) -0.65 -0.74 -0.69 -0.47 -0.78
EBITDA -22.25M -30.83M -27.70M -13.74M -22.20M
Depreciation & Amortization 204.62K 121.75K 77.96K 55.06K 36.82K